Articles
Happy Holidays to all of the readers of Follicle Thought. I’m pleased to be bringing you all an exclusive interview with the UK-based startup HairClone, I hope you enjoy it with your celebrations this year. As many of you know, HairClone has recently launched a crowdfunding campaign in order to advance its R&D and setup…
Read More
A clinical trial has begun for HairCell, a startup in the Leonhardt Ventures portfolio which seeks to rejuvenate hair using bioelectric stimulation and biologics. Leonhardt Ventures is a regenerative medtech company which is developing around 30 startup companies for various types of organ regeneration and recovery. The core technology of all of these companies is…
Read More
In November, the UK based magazine “Cosmetic Business” released a Trend Report on the latest happenings in the hair growth industry. The November Trend Report features commentary from several hair transplant surgeons and also from yours truly, FollicleThought.com. On The Horizon Within the article, hair transplant surgeon Dr. Robert Jones endorses HairClone on being at…
Read More
Fidia Pharma held a press conference on November 29, 2018 announcing the arrival of Trinov hair growth lotion at pharmacies in Italy. The press release was shared in the news section of Fidia’s website, only in the Italian version of the website. Upon first glance this was good news to read, however when I clicked on…
Read More(Update: Minimum investment in HairClone is now £100) HairClone, a UK based company working on cellular hair restoration therapies, has announced the launch of its public crowdfunding campaign today. Please enjoy the introductory HairClone crowdfunding video below. To launch the campaign HairClone has teamed up with Capital Cell, a European based equity crowdfunding company which specializes…
Read More
Today, I will be sharing some expanded information I have received about the exciting new hair growth cosmetic “NGF-574H” from Medipost of South Korea. Earlier this year in May, I initially covered Medipost’s development of NGF-574H. The product itself is a stem cell-derived serum which has been tailored to be effective at preventing hair loss…
Read More
Updated 2/28/20 Samumed SM04554 Phase 3 Trial Is Now Fully Enrolled In a company newsletter published on February 28, 2020, Samumed announced that their phase 3 trial of SM04454 in AGA has finally reached its quota of trial participants. That quota was a whopping 625 male subjects between the ages of 18 – 45 years…
Read More
(Updated Below) As the company promised to do earlier this month, Follicum has released data from its phase 2a study which concluded in August earlier this year. This was the first trial Follicum conducted using FOL-005, a modified peptide, on human scalps. In this recent scalp study, five doses (including placebo) were evaluated where patients…
Read More
One of the most fascinating companies in the hair restoration industry, HairClone, has been featured in the latest edition of the UK’s Consulting Room online magazine. The article features commentary from HairClone CEO Paul Kemp PhD and Medical Director Dr. Bessam Farjo. The article by Lorna Jackson is very detail oriented and provides a comprehensive…
Read More
According to its latest news update, Follicum will present top-line data from its recent phase 2a trial by the end of the month. The phase 2a trial for Follicum’s hair growth candidate FOL-005 was completed at sites in Hamburg and Berlin, Germany at the end of August this year. The study comprised 60 patients (assumed…
Read More